Publication | Closed Access
Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients
59
Citations
0
References
2003
Year
EngineeringCancer PathologyTgf β1Radiation EffectGenetic EpidemiologyRadiation ExposurePathologyHuman PolymorphismRadiation BiologyTumor BiologyRadiation MedicineBreast Cancer PatientsRadiation-induced DamageMolecular DiagnosticsRadiation OncologyMolecular OncologyCancer ResearchGrowth Factor Beta-1Normal TissuesRadiation TherapyMedicineCancer GeneticsRadiation EffectsCancer RiskBreast CancerOncology
Purpose : To investigate whether transforming growth factor beta-1 (TGF β1) single nucleotide polymorphisms were associated with the susceptibility of breast cancer patients to severe radiationinduced normal tissue damage. Materials and methods : PCR-RFLP assays were performed for TGF β1 gene polymorphisms on DNA obtained from 103 breast cancer patients who received radiotherapy. The G −800A, C −509T, T+869C and G+915C polymorphic sites were examined, and genotype and allele frequencies of two subgroups of patients were calculated and compared. Results : The less prevalent −509T and +869C alleles were significantly associated with a subgroup of patients who developed severe radiation-induced normal tissue fibrosis (n =15) when compared with those who did not (n =88) (odds ratio=3.4, p =0.0036, and 2.37, p =0.035, respectively). Furthermore, patients with the −509TT or +869CC genotypes were between seven and 15 times more likely to develop severe fibrosis. Conclusions : These findings imply a role for the −509T and +869C alleles in the pathobiological mechanisms underlying susceptibility to radiation-induced fibrosis. Their predictive value would be limited to patients who are −509TT or +869CC, but if 'fibrosis-associated' polymorphic sites in other genes could be identified, it may be possible to detect fibrosis prone individuals before radiotherapy with greater certainty.